Biogen | BIIB - 借入資本





借入資本 変化する 日付
AbbVie USD 58.94B 4.03B 2025-12
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 285.82M 639K 2024-09
Amgen USD 51.89B 1.88B 2026-03
Bayer EUR 31.83B 877M 2025-12
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
Incyte USD 29.41M 785K 2026-03
Merck USD 46.67B 77M 2026-03
Moderna USD 603M 7M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.57B 1.08B 2026-03
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 13.84B 1.88B 2026-03
Sanofi EUR 15.72B 150.06M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03
Ultragenyx Pharmaceutical USD 1.15B 383.26M 2025-12
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12